Zerhouni resigns as NIH head

The 15th head of the National Institutes of Health, linkurl:Elias Zerhouni,;http://www.the-scientist.com/blog/display/42733/ will step down from his post, he announced today (Sept 24). In a conference call with reporters today, Zerhouni said that he would be leaving NIH at the end of October as a part of what he called "the natural cycle of tenures for this position." "It's with mixed emotions that I move on," he said. President George W. Bush linkurl:appointed;http://www.the-scientist.com/ar

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The 15th head of the National Institutes of Health, linkurl:Elias Zerhouni,;http://www.the-scientist.com/blog/display/42733/ will step down from his post, he announced today (Sept 24). In a conference call with reporters today, Zerhouni said that he would be leaving NIH at the end of October as a part of what he called "the natural cycle of tenures for this position." "It's with mixed emotions that I move on," he said. President George W. Bush linkurl:appointed;http://www.the-scientist.com/article/display/13166/ Zerhouni in May 2002, on the tail end of a five year NIH budget doubling. These halcyon days at NIH led Zerhouni to craft the linkurl:"NIH Roadmap for Medical Research,";http://www.the-scientist.com/article/display/14454/ a sweeping $2 billion, five-year plan meant to invigorate the biomedical enterprise through focusing NIH resources on bioinformatics, systems and structural biology, genomic database establishment, and nanomedicine projects, encouraging cross-disciplinary collaboration, and funding clinical and translational research. "I think it's clear that science has changed tremendously with the explosion of discoveries," Zerhouni said on the conference call. The Roadmap will likely form the base of Zerhouni's legacy at NIH, but he saw the agency through his fair share of controversy and turmoil as well. On Zerhouni's watch the NIH budget plateaued, and federal funding of the agency remains level today. He also watched the success rates for new R01 grants linkurl:plummet;http://www.the-scientist.com/2008/9/1/30/1/ from about 18% in 2002 to about 9% in 2005. Zerhouni received criticism for his appointment of David Schwartz, former director of the National Institute of Environmental Health Sciences, who linkurl:resigned;http://www.the-scientist.com/blog/display/54296/ from his post earlier this year amid allegations of mismanagement and misconduct. Senator Charles Grassley (R-IA) corresponded frequently with Zerhouni regarding NIH-funded scientists who the Senator alleged improperly disclosed financial ties to industry. Prior to his appointment as head of NIH, the Algerian-born radiologist was the executive vice-dean of Johns Hopkins University School of Medicine and a professor of radiology and biomedical engineering there and at Eastern Virginia Medical School. Zerhouni said today that he doesn't "have a job lined up," and that he plans on resting before transitioning into a new position. "I wanted to take some time out," he said.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control